Ethyl pyruvate is a novel anti-inflammatory agent to treat multiple inflammatory organ injuries

Journal of Inflammation (United Kingdom)

Volumn 13, Issue 1, 2016, Pages

  Yang, Runkuan ^a,b,c   Zhu, Shengtao ^d   Tonnessen, Tor Inge ^c  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OSLO   (Norway)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Ethyl pyruvate; HMGB1; Inflammation; Reactive oxygen species

Indexed keywords

ANTIINFLAMMATORY AGENT; ETHYL PYRUVATE; HEME OXYGENASE 1; HIGH MOBILITY GROUP B1 PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERLEUKIN 8; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ALCOHOL LIVER CIRRHOSIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN ISCHEMIA; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; FATTY LIVER; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATORY BOWEL DISEASE; LIPID PEROXIDATION; LIVER INJURY; MULTIPLE ORGAN FAILURE; NEUROPROTECTION; NONHUMAN; OBSTRUCTIVE JAUNDICE; OXIDATIVE STRESS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SUBARACHNOID HEMORRHAGE; TOXIC HEPATITIS; TRAUMATIC BRAIN INJURY; VIRUS MYOCARDITIS;

EID: 85000761530     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/s12950-016-0144-1     Document Type: Article

References (98)

1. Fink MP. Ethyl pyruvate. Curr Opin Anaesthesiol. 2008;21:160-7.
2. Kao K, Fink MP. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem Pharmacol. 2010;80:151-9.
3. Yang Z, Meng X, Xu P. Central role of neutrophil in the pathogenesis of severe acute pancreatitis. J Cell Mol Med. 2015;19:2513-20.
4. Luan ZG, Ma XC, Zhang H, Zhang C, Guo RX. Protective effect of ethyl pyruvate on pancreas injury in rats with severe acute pancreatitis. J Surg Res. 2013;181:76-84.
5. Hegazi R, Raina A, Graham T, Rolniak S, Centa P, Kandil H, O'keefe SJ. Early jejunal feeding initiation and clinical outcomes in patients with severe acute pancreatitis. J Parenter Enteral Nutr. 2011;35:91-6.
6. Yang R, Uchiyama T, Alber SM, Han X, Watkins SK, Delude RL, Fink MP. Ethyl pyruvate ameliorates distant organ injury in a murine model of acute necrotizing pancreatitis. Crit Care Med. 2004;32:1453-9.
7. Tadao M, Yuji O. Role of free radicals in the development of severe acute pancreatitis. Nihon Rinsho. 2004;62:2015-20.
8. Akbarshahi H, Rosendahl AH, Westergren-Thorsson G, Andersson R. Acute lung injury in acute pancreatitis-awaiting the big leap. Respir Med. 2012;106:1199-210.
9. Yuan Z, Meyerholz DK, Twait EC, Kempuraj D, Williard DE, Samuel I. Systemic inflammation with multiorgan dysfunction is the cause of death in murine ligation-induced acute pancreatitis. J Gastrointest Surg. 2011;15:1670-8.
10. Yang Z, Ling Y, Yin T, Tao J, Xiong J, Wu H, Wang C. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats. World J Gastroenterol. 2008;14:4546-50.
11. Cheng B, Liu C, Li W, Fan W, Zhong N, Zhang Y, Jia X, Zhang SZ. Ethyl pyruvate improves survival and ameliorates distant organ injury in rats with severe acute pancreatitis. Pancreas. 2007;35:256-61.
12. Yang R, Shaufl AL, Killeen MK, Fink MP. Ethyl pyruvate ameliorates liver injury secondary to severe acute pancreatitis. JSR. 2009;153:302-9.
13. Luan Z, Zhang H, Ma X, Zhang C, Guo R. Therapeutic treatment with ethyl pyruvate attenuates the severity of liver injury in rats with severe acute pancreatitis. Pancreas. 2012;41:729-37.
14. Shen X, Li WQ. High-mobility group box 1 protein and its role in severe acute pancreatitis. World J Gastroenterol. 2015;1:1424-35.
15. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. JEM. 2005;201:1135-43.
16. Sappington PL, Yang R, Yang H, Tracey KJ, Deluder RL, Fink MP. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology. 2002;123:790-802.
17. Yang R, Zhang S, Cotoia A, Oksala N, Zhu S, Tenhunen J. High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicity. BMC Gastroenterol. 2012;12:45.
18. Antoine DJ, Williams DP, Kipar A, Laverty H, Park BK. Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity. Mol Med. 2010;16:479-90.
19. Lau A, Wang S, Liu W, Haig A, Zhang Z, Jevnikar AM. Glycyrrhizic acid ameliorates HMGB1-mediated cell death and inflammation after renal ischemia reperfusion injury. Am J Nephrol. 2014;40:84-95.
20. Hu Y, Pai MH, Yeh CL, Hou YC, Yeh SL. Glutamine administration ameliorates sepsis-induced kidney injury by downregulating the high- mobility group box protein-1-mediated pathway in mice. Am J Physiol Renal Physiol. 2012;302:F150-8.
21. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Nakajima T, Kuroda Y. Blokade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol. 2006;12:7666-70.
22. Kao RL, Xu X, Xenocostas A, Parry N, Mele T, Martin CM, Rui T. Induction of acute lung inflammation in mice with hemorrhagic shock and reperfusion: role of HMGB1. J Inflamm (Lond). 2014;11:30-7.
23. Tsai BM, Lahm T, Morrell EI, Crisostomo PR, Poynter J, Wang M, Meldrum DR. Ethyl pyruvate inhibits hypoxic pulmonary vasoconstriction and attenuates pulmonary artery cytokine expressions. J Surg Res. 2008;145:130-4.
24. Luan Z, Zhang X, Yin X, Ma X, Zhang H, Zhang C, Guo R. Downregulation of HMGB1 protects against the development of acute lung injury after severe acute pancreatitis. Immunobiology. 2013;218:1261-70.
25. Yang R, Zou X, Tenhunen J, Zhu S, Kajander H, Koskinen M, Tonesseen TI. Neutralization of HMGB1 is associated with bacterial translocation during acetaminophen hepatotoxicity. BMC Gastroenterol. 2014;14:66.
26. Fink MP. Leaky gut hypothesis: a historical perspective. Crit Care Med. 1990;18:579-80.
27. Li Q, Wang C, Tang C, He Q, Li N, Li J. Bacteraemia in patients with acute pancreatitis as revealed by 16 s ribosomal RNA gene-based technique. CCM. 2013;41:1938-50.
28. Fritz S, Hackert T, Hartwig W, Rossmanith F, Strobel O, Schneider L, Will-Schweiger K, Kommerell M, Buchler MW, Werner J. Bacterial translocation and infected pancreatic necrosis in acute necrotizing pancreatitis derives from small bowel rather than from colon. Am J Surg. 2010;200:111-7.
29. Capurso G, Zerboni G, Signoretti M, Valente R, Stigliano S, Piciuchi M, Delle FG. Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol. 2012;46:S46-51.
30. Guo Z, Wang P, Zhu Y, Huang Z, Tang C. The crosstalk between gut inflammation and gastrointestinal disorders during acute pancreatitis. Curr Pharm Des. 2014;20:1051-62.
31. Wang XD, Andersson R, Stoltesz V, Leveau P, Ihse I. Gut origin sepsis, macrophage function, and oxygen extraction associated with acute pancreatitis in the rat. World J Surg. 1996;20:299-308.
32. Chen H, Li F, Jia J, Diao Y, Li Z, Sun J. Effect of traditional Chinese medicine on intestinal mucosal permeability in early phase of severe acute pancreatitis. Chin Med J (Engl). 2010;123:1537-42.
33. Runkel N. Bacterial translocation in acute pancreatitis. Dig Surg. 1996;13:269-72.
34. Fanous M, Phillips AJ, Windsor JA. Mesenteric lymph: The bridge to future management of critical illness. JOP J Pancreas. 2007;8:374-99.
35. Ramadori G, Moroconi F, Malik I, Dudas J. Physiology and pathophysiology of liver inflammation, damage and repair. J physiol Pharmacol. 2008;59:107-17.
36. Gloor B, Blinman TA, Rigberg DA, Todd KE, Lane JS, Hines OJ, et al. Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas. 2000;21:414-20.
37. Yang R, Han X, Delude RL, Fink MP. Ethyl pyruvate ameliorates acute alcoholic-induced liver injury and inflammation in mice. J Lab and Clinic Med. 2003;142:322-31.
38. Yang R, Uchiyama T, Watkins SK, Han X, Fink MP. Ethyl pyruvate reduces liver injury in a murine model of extrahepatic cholestasis. Shock. 2004;22:369-75.
39. Yang R, Zhang S, Kajander H, Zhu S, Koskinen ML, Tenhunen J. Ringer's lactate improves liver recovery in a murine model of acetaminophen toxicity. BMC Gastroenterol. 2011;11:125.
40. Stine JG, Chalasani NP. Drug hepatotoxicity: environmental factors. Clin Liver Dis. 2017;21:103-13.
41. Ole RA, Ziokowski W, Flis DJ, Fedeli D, Fiorini D, Wierzba TH, Gabbianelli R. The effect of ethyl pyruvate supplement on rat fatty liver induced by a high-fat diet. J Nutr Sci Vitaminol (Tokyo). 2013;59:232-7.
42. Shen M, Lu J, Dai W, et al. Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy. Mediators Inflamm. 2013;2013:461536.
43. Yang R, Zou X, Koskinen ML, Tenhunen J. Ethyl pyruvate reduces liver injury at early phase but impairs regeneration at late phase in acetaminophen overdose. Crit Care. 2012;16:R9.
44. Shen M, Lu J, Cheng P, et al. Ethyl pyruvate pretreatment attenuates concanavalin A-induced autoimmune hepatitis in mice. PLoS One. 2014;9:e87977.
45. Wang LK, Wang LW, Li X, Han XQ, Gong ZJ. Ethyl pyruvate prevents inflammatory factors release and decreases intestinal permeability in rats with D-galactosamine-induced acute liver failure. Hepatobiliary Pancreat Dis Int. 2013;12:180-8.
46. Wang LW, Wang LK, Chen H, Fan C, Li X, He CM, Gong ZJ. Ethyl pyruvate protects against experimental acute-on-chronic liver failure in rats. World J Gastroenterol. 2012;18:5709-18.
47. Akkoc H, Kelle I, Tunik S, Bahceci S, Sencar L, Ayaz E, Nergiz Y, Erdinc L, Erdinc M. Protective effect of ethyl pyruvate on liver injury in diabetic strptozotocin-induced rats. Acta Gastroenterol Belg. 2012;75:336-41.
48. Andersson B, Ansari D, Andersson E, Persson S, Andersson R. Fatal acute pancreatitis occurring outside of the hospital: clinical and social characteristics. World J Surg. 2010;34:2286-91.
49. Pastor CM, Matthay MA, Frossard JL. Pancreatitis-associated acute lung injury: new insights. Chest. 2003;124:2341-51.
50. Shields CJ, Winter DC, Redmond HP. Lung injury in acute pancreatitis: mechanism, prevention, and the therapy. Curr Opin Crit Care. 2002;8:158-63.
51. Zhao X, Andersson R, Wang X, Dib M. Acute pancreatitis-associated lung injury: pathophysiological mechanisms and potential future therapies. Scand J Gastroenterol. 2002;37:1351-8.
52. Matone J, Moretti AI, Apodaca-Torrez FR, Goldenberg A. Ethyl pyruvate reduces lung injury matrix metalloproteinases and cytokines and improves survival in experimental model of severe acute pancreatitis. Acta Cir Bras. 2013;28:559-67.
53. Luan ZG, Zhang J, Yin XH, Ma XC, Guo RX. Ethyl pyruvate significantly inhibits tumor necrosis factor-α interleukin-1 and high mobility group box 1 releasing and attenuates sodium taurocholate-induced severe acute pancreatitis associated acute lung injury. Clin Exp Immunol. 2013;172:417-26.
54. Relja B, Omid N, Schaible A, Perl M, Meier S, Oppermann E, Lehnert M, Marzi I. Pre-or post-treatment with ethanol and ethyl pyruvate results in distinct anti-inflammatory response of human lung epithelial cells triggered by interleukin-6. Mol Med Rep. 2015;12:2991-8.
55. Relja B, Omid N, Wagner N, Mors K, Werner I, Perl M, Marzi I. Ethanol, ethyl and sodium pyruvate decrease the inflammatory response of human lung epithelial cells via Akt and NF-kB in vitro but have low impact on hepatocellular cells. Int J Mol Med. 2016;37:517-25.
56. Kung CW, Lee YM, Cheng PY, Peng YJ, Yen MH. Ethyl pyruvate reduces acute lung injury via regulation of iNOS and HO-1 expression in endotoxemic rats. J Surg Res. 2011;167:e323-31.
57. Shang GH, Lin DJ, Xiao W, Jia CQ, Li Y, Wang AH, Dong L. Ethyl pyruvate reduces mortality in an endotoxin-induced severe acute lung injury mouse model. Respir Res. 2009;10:91.
58. Entezari M, Javdan M, Antoine DJ, et al. Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury. Redox Biol. 2014;2:314-22.
59. Tian XX, Wu CX, Sun H, Gong JP, Liu Q, Guo H. Ethyl pyruvate inhibited HMGB1 expression induced by LPS in macrophages. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011;27:1304-7.
60. Jang HJ, Kim YM, Tsoyi K, Park EJ, Lee YS, Kim HJ, Lee JH, Joe Y, Chung HT, Chang KC. Ethyl pyruvate induces heme oxygenase-1 through p38 mitogen-activated protein kinase activation by depletion of glutathione in Raw 264.7 cells and improves survival in septic animals. Antioxid Redox Signal. 2012;17:878-89.
61. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP, Tracey KJ. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci. 2002;99:12351-6.
62. Gazzar ME. HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm Res. 2007;56:162-7.
63. Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A. 2010;26:11942-7.
64. Kang H, Mao Z, Zhao Y, Yin T, Song Q, Pan L, Hu X, Hu J, Zhou F. Ethyl pyruvate protects against sepsis by regulating energy metabolism. Ther Clin Risk Manag. 2016;12:287-94.
65. Jiang Z, Li X, Lin Z, Chen J, Guan X, Chen M. Ethyl pyruvate reduces hepatic mitochondrial swelling and dysfunction in a rat model of sepsis. Int J Clin Exp Pathol. 2015;8:7774-85.
66. Zheng YJ, Xu WP, Ding G, Gao YH, Wang HR, Pan SM. Expression of HMGB1 in septic serum induces vascular endothelial hyperpermeability. Mol Med Rep. 2016;13:513-21.
67. Wang G, Liu K, Li Y, Yi W, Yang Y, Zhao D, Fan C, Yang H, Geng T, Xing J, Zhang Y, Tan S, Yi D. Endoplasmic reticulum stress mediates the anti-inflammatory effect of ethyl pyruvate in endothelial cells. PLoS One. 2014;9:e113983.
68. Miyaji T, Hu X, Yuen PS, Muramatsu Y, Lyer S, Hewitt SM, Star RA. Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int. 2003;64:1620-31.
69. Ju KD, Shin EK, Cho EJ, Yoon HB, Kim H, Yang J, Hwang YH, Ahn C, Oh KH. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy. Am J Physiol Renal Physiol. 2012;302:F606-13.
70. Kelle I, Akkoc H, Tunik S, Nergiz Y, Erdinc M, Erdinc L. Protective effects of ethyl pyruvate in cisplatin-induced nephrotoxicity. Biotechnol Biotechnol Equip. 2014;28:674-80.
71. Yu Y, Liu M, Yu P, Liu G, Liu Y, Su Y, Jiang H, Chen R. Ethyl pyruvate attenuated coxackievirus B3-induced acute viral myocarditis by suppressing of HMGB1/RAGE/NF-kB pathway. Springerplus. 2016;5:215.
72. Lin Y, Chen L, Li W, Fang J. Role of high-mobility group box 1 in myocardial ischemia/reperfusion injury and the effect of ethyl pyruvate. Exp Ther Med. 2015;9:1537-41.
73. Guo J, Zhang J, Luo X, Luo W, Lin C, Zhang K, Ji Y. Effects of ethyl pyruvate on cardiac function recovery and apoptosis reduction after global cold ischemia and reperfusion. Exp Ther Med. 2014;7:1197-202.
74. Jang IS, Park MY, Shin IW, Sohn JT, Lee HK, Chung YK. Ethyl pyruvate has anti-inflammatory and delayed myocardial protective effects after regional ischemia/reperfusion injury. Yonsei Med J. 2010;51:838-44.
75. Woo YJ, Taylor MD, Cohen JE, Jayasankar V, Bish LT, Burdick J, Pirolli TJ, Berry MF, Hsu V, Grand T. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia. J Thorac Cardiovasc Surg. 2004;127:1262-9.
76. Moro N, Sutton RL. Beneficial effects of sodium or ethyl pyruvate after traumatic brain injury in the rat. Exp Neurol. 2010;225:391-401.
77. Su X, Wang H, Zhao J, Pan H, Mao L. Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NFkB pathway after traumatic brain injury in the rat. Mediators Inflamm. 2011;2011:807142.
78. Shi H, Wang HL, Pu HJ, Shi YJ, Zhang J, Zhang WT, Wang GH, Hu XM, Leak RK, Chen J, Gao YQ. Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury. CNS Neurosci Ther. 2015;21:374-84.
79. Moro N, Ghavim SS, Harris NG, Hovda DA, Sutton RL. Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after traumatic experimental brain injury. Brain Res. 2016;1642:270-7.
80. Su X, Wang H, Zhu L, Zhao J, Pan H, Ji X. Ethyl pyruvate ameliorates intracerebral hemorrhage-induced brain injury through anti-cell death and anti-inflammatory mechanisms. Neuroscience. 2013;245:99-108.
81. Li D, Lei C, Zhang S, Zhang S, Liu M, Wu B. Blockade of high mobility group box-1 signaling via the receptor for advanced glycation end-products ameliorates inflammatory damage after acute intracerebral hemorrhage. Neurosci Lett. 2015;609:109-19.
82. Fang R, Zheng X, Zhang M. Ethyl pyruvate alleviates early brain injury following subarachnoid hemorrhage in rats. Acta Neurochir (Wien). 2016;158:1069-76.
83. Yu YM, Kim JB, Lee KW, Kim SY, Han PL, Lee JK. Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window. Stroke. 2005;36:2238-43.
84. Rong Z, Pan R, Chang L, Lee W. Combination treatment with ethyl pyruvate and IGF-I exerts neuroprotective effects against brain injury in a rat model of neonatal hypoxic-ischemic encephalopathy. Int J Mol Med. 2015;36:195-203.
85. Guo X, Guo R, Luo X, Zhou L. Ethyl pyruvate ameliorates experimental colitis in mice by inhibiting the HMGB1-Th17 and Th1/Tc1 responses. Int Immunopharmacol. 2015;29:454-61.
86. Algien F, Rodriguez-Nogales A, Garrido-Mesa J, Camuesco D, Vezza T, Garrido- Mesa N, Utrilla P, Rodriguez-Cabezas ME, Pischel I, Galvez J. Intestinal anti- inflammatory activity of calcium pyruvate in the TNBS model of rat colitis: comparison with ethyl pyruvate. Biochem Pharmacol. 2016;103:53-63.
87. Liang X, Chavez AR, Schapiro NE, Loughran P, Thorne SH, Amoscato AA, Zeh HJ, Beer-Stolz D, Lotze MT, de Vera ME. Ethyl pyruvate administration Inhibits hepatic tumor growth. J Leukoc Biol. 2009;86:599-607.
88. Muller AJ, Duhadaway JB, Jaller D, Curtis P, Metz R, Prendergast GC. Immunotherapeutic suppression of indoleamine 2, 3-dioxygenase and tumor growth with ethyl pyruvate. Cancer Res. 2010;70:1845-53.
89. Park SY, Yi EY, Jung M, Lee YM, Kim YJ. Ethyl pyruvate, an anti- inflammatory agent, inhibits tumor angiogenesis through inhibition of NF-kB signaling pathway. Cancer Lett. 2011;303:150-4.
90. Zhang J, Zhu JS, Zhou Z, Chen WX, Chen NW. Inhibition effects of ethyl pyruvate administration on human gastric cancer growth via regulation of HMGB1-Rage and Akt pathways in vitro and in vivo. Oncol Rep. 2012;27:1511-9.
91. Li ML, Wang XF, Tan ZJ, et al. Ethyl pyruvate administration suppresses growth and invasion of gallbladder cancer cells via downregulation of HMGB1-RAGE axis. Int J Immunopathol Pharmacol. 2012;25:955-65.
92. Yan HX, Wu HP, Zhang HL, Ashton C, Tong C, Wu H, Qian QJ, Wang HY, Ying QL. P53 promotes inflammation-associated hepatocarcinogenesis by Inducing HMGB1 release. J Hepatol. 2013;59:762-8.
93. Cheng P, Dai W, Wang F, et al. Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of HMGB1- RAGE and Akt pathways. Biochem Biophys Res Commun. 2014;443:1162-8.
94. Baunacke M, Horn LC, Trettner S, Engel KM, Hemdan NY, Wiechmann V, Stolzenburg JU, Bigl M, Birkenmeier G. Exploring glyoxalase 1 expression in prostate cancer tissues: targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties. Prostate. 2014;74:48-60.
95. Dave SH, Tilstra JS, Matsuoka K, Li F, DeMarco RA, Beer-Stolz D, Sepulveda AR, Fink MP, Lotze MT, Plevy SE. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol. 2009;86:633-43.
96. Mizutani A, Maeda N, Toku S, Higa-Nakamine S, Isohama Y, Sunakawa H, Suqahara K, Yamamoto H. Interaction of ethyl pyruvate in vitro with NF-kB subunits, Rel A and p50. Eur J Pharmacol. 2011;605:151-6.
97. Shin JH, Kim ID, Kim SW, Lee HK, Jin Y, Park JH, Kim TK, Suh CK, Kwak J, Lee KH, Han PL, Lee JK. Ethyl pyruvate inhibits HMGB1 phosphorylation and release by chelating calcium. Mol Med. 2015;20:649-57.
98. Kim SW, Lee HK, Kim HJ, Yoon SH, Lee JK. Neuroprotective effect of ethyl pyruvate against Zn (2+) toxicity via NAD replenishment and direct Zn αα2+) chelation. Neuropharmacology. 2016;105:411-9.